Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?Kenneth Blum1-6,8*, Marlene Oscar-Berman7, Seth H Blum9, Margaret A Madigan6, Roger L Waite6, Thomas McLaughlin9 and Debmalya Barh5
- *Corresponding Author:
- Kenneth Blum
Department of Psychiatry & McKnight Brain Institute
University of Florida College of Medicine, Gainesville, FL, USA
E-mail: [email protected]
Received date: May 01, 2014; Accepted date: May 26, 2014; Published date: May 29, 2014
Citation: Blum K, Oscar-Berman M, Blum SH, Madigan MA, Waite RL et al., (2014) Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?. J Alcohol Drug Depend 2:161. doi: 10.4172/2329-6488.1000161
Copyright: © 2014 Blum K et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
An overwhelming segment of the world’s population possesses certain genetic variations that increase risk for genetic predispositions to substance seeking and even behavioral addictions (e.g. gambling, internet gaming, multiple sex partners etc.) that preclude them from reaching their optimum health potential, contribute to impaired health, and/or can cause involuntary indulgence in detrimental and self-destructive behaviors.